Whitman Craig B, Schroeder Walter S, Ploch Peter J, Raghavendran Krishnan
Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
Pharmacotherapy. 2008 Jan;28(1):131-5. doi: 10.1592/phco.28.1.131.
Cardiac dysrhythmias and cardiac arrest can occur after acute spinal cord injury (SCI). Disrupted sympathetic innervation after SCI results in unopposed parasympathetic activity leading to baseline bradycardia. Hence, vagal stimulation can result in episodes of exaggerated symptomatic bradycardia. Data supporting pharmacologic intervention for treatment of symptomatic bradycardia after SCI are limited. We describe a patient who sustained a high cervical SCI and subsequently developed episodic symptomatic bradycardia. The addition of aminophylline to the patient's therapeutic regimen was associated with resolution of the bradycardia. Throughout her treatment course, the patient's serum theophylline concentrations were 1.9-3.4 mg/L. These levels were consistent with those identified in other case reports describing treatment with methylxanthines to prevent episodic bradycardia after SCI. Our understanding of drug pharmacokinetics and pharmacodynamics in patients with acute SCI is limited and provides an ideal opportunity for further study in this area.
急性脊髓损伤(SCI)后可发生心律失常和心脏骤停。SCI后交感神经支配中断导致副交感神经活动无对抗,从而引起基础心动过缓。因此,迷走神经刺激可导致症状性心动过缓发作加剧。支持药物干预治疗SCI后症状性心动过缓的数据有限。我们描述了一名发生高位颈髓SCI并随后出现发作性症状性心动过缓的患者。在患者的治疗方案中加用氨茶碱后,心动过缓得到缓解。在整个治疗过程中,患者的血清茶碱浓度为1.9 - 3.4mg/L。这些水平与其他描述用甲基黄嘌呤治疗以预防SCI后发作性心动过缓的病例报告中所确定的水平一致。我们对急性SCI患者药物药代动力学和药效学的了解有限,这为该领域的进一步研究提供了理想的机会。